Cahill Represents Lead Arrangers in QuidelOrtho’s $3.4 Billion Credit Facility

August 21, 2025

Cahill represented the lead arrangers in connection with a $1.15 billion Term A credit facility, a $100 million delayed draw Term A facility, a $1.45 billion Term B credit facility, and a $700 million revolving credit facility for QuidelOrtho Corporation.

Proceeds from the credit facility will be used for general corporate purposes and a refinancing existing credit.

QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products.